Reply to T.J. Kruser et al.

Autor: Chinot OL; Aix-Marseille University, AP-HM, Centre Hospitalier Universitaire Timone, Marseille, France olivier.chinot@ap-hm.fr., Taphoorn MJ; Medical Center Haaglanden, The Hague, and VU University Medical Center, Amsterdam, the Netherlands., Bais C; Genentech, South San Francisco, CA., Bourgon R; Genentech, South San Francisco, CA., Phillips HS; Genentech, South San Francisco, CA., Abrey LE; F. Hoffmann-La Roche, Basel, Switzerland., Wick W; University Medical Center, Heidelberg, Germany., Mason W; Princess Margaret Hospital, Toronto, Ontario, Canada., Henriksson R; Regional Cancer Center Stockholm, Stockholm, and Umeå University, Umeå, Sweden., Saran F; The Royal Marsden National Health Service Foundation Trust, Surrey, United Kingdom., Nishikawa R; Saitama Medical University, Saitama, Japan., Cloughesy T; University of California, Los Angeles, Los Angeles, CA.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Apr 10; Vol. 34 (11), pp. 1282-3. Date of Electronic Publication: 2016 Feb 16.
DOI: 10.1200/JCO.2015.65.2438
Databáze: MEDLINE